CYM2503
Cat. No.：YN322227
| 产品名称: | CYM2503 |
| CAS No.: | 1308833-36-4 |
| Chemical Name: | 3-cyclohexyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanyl-N-(1,2-dihydro-4-methyl-2-oxo-7-quinolinyl)-N6-[(1,1-dimethylethoxy)carbonyl]-L-lysinamide |
| Synonyms: | |
| 分子量: | 778 |
| 分子式: | C45H55N5O7 |
| SMILES: | CC(C1=CC=C(C=C1N2)NC([C@H](CCCCNC(OC(C)(C)C)=O)NC([C@H](CC3CCCCC3)NC(OCC4C5=CC=CC=C5C6=CC=CC=C64)=O)=O)=O)=CC2=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | CYM2503 是一种推定的 GalR2 阳性变构调节剂。CYM2503 增加了第一次电图癫痫发作的潜伏期并减少了癫痫发作的总时间。CYM2503 还能减轻小鼠电击诱发的癫痫发作。甘丙肽受体 1 型 (GalR1) 和/或 2 型 (GalR2) 代表了癫痫发作和癫痫研究的独特药理学靶点。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Lu, X., Roberts, E., Xia, F., et al.GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal modelsProc. Natl. Acad. Sci. USA107(34),15229-15234(2010)
